摘要
Nicotine use is more prevalent in patients with psychiatric disorders,especially those diagnosed with psychotic illnesses.Previously,this higher prevalence has been partially attributed to the potential ameliorative effects of nicotine on symptom severity and cognitive impairment.Some healthcare professionals and patients perceive there is a beneficial effect of nicotine on mental health.Emerging data show that the harm associated with nicotine in the population of patients with mental health conditions outweighs any potential benefit.This paper will review the evidence surrounding the nicotinic system and schizophrenia,with a focus on any causality between nicotine and psychosis.
作者简介
Correspondence:Guna Kanniah graduated with a B.Pharm.(Hons)from Universiti Sains Malaysia(1978)and M.Clin.Pharmacy(1993)and completed PG Cert.Psychopharmacotherapy from Auckland University,New Zealand,in 2007-2008.He participates in MDTs,patient counselling,in-service training,patient care plans,assessment reviews,medication reviews,and complex case reviews.He lectures in the psychiatric registrar training programme.He regularly presents at Mental Health SIG seminars,psychiatric and pharmacy journal clubs and hospital grand rounds.He has delivered oral presentations at the Clinical Pharmacy Congress Zurich 2018,WFSBP Congress 2017,Copenhagen,WFSBP Congress 2015,Athens,Medication Safety in Mental Health 2011,Adelaide,ISAD 2009 Asia-Pacific Regional Conference,Brisbane,CINP 2008 Asia-Pacific Conference,Kuala Lumpur,GP Conference 2012,Roturua,NZ,NZHPA Conference 2006,2007,2008,2009,2010.He has published several papers in psychiatric journals,guna.kanniah@waikatodhb.health.nz,ORCID iD:http://orcid.org/0000-0002-9598-3091。
